SRSA
BMY icon

S.R. Schill & Associates’s Bristol-Myers Squibb BMY Stock Holding History

S.R. Schill & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,612
Closed -$214K – 77
2021
Q3 		$214K Buy
+3,612
New +$238K 0.09% 83

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

S.R. Schill & Associates's BMY Position: Q4 2021 in Review

S.R. Schill & Associates sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 3,612 shares — an estimated $214K sold.

S.R. Schill & Associates first reported a position in BMY in Q3 2021 and held it in 1 quarter. The position peaked at $214K in Q3 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • S.R. Schill & Associates reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • S.R. Schill & Associates sold 3,612 Bristol-Myers Squibb shares in Q4 2021, an estimated $214K.
  • S.R. Schill & Associates first reported a position in Bristol-Myers Squibb in Q3 2021 and held it in 1 quarter.
  • S.R. Schill & Associates's Bristol-Myers Squibb position peaked at $214K in Q3 2021.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on S.R. Schill & Associates's 13F filing for Q4 2021, filed 14 Feb 2022.